{"id":149332,"date":"2026-11-11T18:43:52","date_gmt":"2026-11-11T09:43:52","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/8275-20261111-01_wp_financial_summary\/"},"modified":"2026-11-11T18:43:52","modified_gmt":"2026-11-11T09:43:52","slug":"8275-20261111-01_wp_financial_summary","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/","title":{"rendered":"Financial Summary for the Second Quarter (Interim) of Fiscal Year Ending March 2027"},"content":{"rendered":"<p>Interim net sales were 35,436 million yen (Year-over-Year (YoY) increase of 4.4%), operating income 1,265 million yen (YoY increase of 5.2%), and net income attributable to owners of parent for the interim period was 616 million yen (YoY increase of 2.4%). There is no change to the full-year earnings forecast. Segments were reorganized into two categories: Corporate Doctor Group and Business Solutions Group. Cash and cash equivalents at the end of the period were approximately 10.31 hundred million yen, and the equity ratio was 45.7%.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8275","jir_company_name":"Forval Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-11","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/8275-20261111-01.pdf","jir_short_summary":"Interim net sales were 35,436 million yen (Year-over-Year (YoY) increase of 4.4%), operating income 1,265 million yen (YoY increase of 5.2%), and net income attributable to owners of parent for the interim period was 616 million yen (YoY increase of 2.4%). There is no change to the full-year earnings forecast. Segments were reorganized into two categories: Corporate Doctor Group and Business Solutions Group. Cash and cash equivalents at the end of the period were approximately 10.31 hundred million yen, and the equity ratio was 45.7%.","jir_summary":"### Overview of Performance\nNet sales for the interim period increased year-on-year, driven by expansion of services in the information and communications field including cloud, big data and AI utilization. Operating income, ordinary income and interim net income all increased compared with the previous fiscal year. Segments were newly organized into two categories: Corporate Doctor Group and Business Solutions Group, and reporting has been aligned with the actual management structure. Cash and deposits decreased, but the equity ratio remains stable.\n\n### Outlook and Capital Allocation\nThere is no change to the full-year earnings forecast and no announced change to dividend policy. Financial condition is solid; despite a net decrease in cash, the company intends to continue business investments and strengthen human resources. Business expansion through promotion of DX and GX with regions and local governments and the promotion of human capital management are positioned as pillars for long-term growth.","jir_financial_highlights":"Net Sales: 35,436 million yen (YoY increase of 4.4%)\nOperating Income: 1,265 million yen (YoY increase of 5.2%)\nOrdinary Income: 1,463 million yen (YoY increase of 8.5%)\nNet Income Attributable to Owners of Parent (Interim): 616 million yen (YoY increase of 2.4%)\nTotal Assets: 40,962 million yen\nEquity Ratio: 45.7%","jir_category":"","jir_hashtags":"#Forval, #Earnings, #InterimResults","jir_key_figures":"Net Sales: 35,436 million yen (YoY increase of 4.4%)\nOperating Income: 1,265 million yen (YoY increase of 5.2%)\nNet Income Attributable to Owners of Parent (Interim): 616 million yen (YoY increase of 2.4%)","jir_meta_title":"Forval Corporation Interim Results: Net Sales Exceed 36 Hundred Million Yen \u2014 Continued Stable Growth | November 11, 2026","jir_meta_description":"Summary of Forval Corporation's financial results for the second quarter (interim) of the fiscal year ending March 2027. Net sales were 35,436 million yen, operating income 1,265 million yen, ordinary income 1,463 million yen, and interim net income 616 million yen. Includes segment restructuring and future growth strategy.","jir_og_title":"Key Points of Forval Corporation Interim Results | November 11, 2026","jir_og_description":"Forval Corporation's Q2 interim results: Net sales 35,436 million yen, operating income 1,265 million yen. Company aims for growth through DX and GX initiatives.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57189,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-149332","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Financial Summary for the Second Quarter (Interim) of Fiscal Year Ending March 2027 - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/\",\"name\":\"Financial Summary for the Second Quarter (Interim) of Fiscal Year Ending March 2027 - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-11-11T09:43:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Financial Summary for the Second Quarter (Interim) of Fiscal Year Ending March 2027\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Financial Summary for the Second Quarter (Interim) of Fiscal Year Ending March 2027 - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/","url":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/","name":"Financial Summary for the Second Quarter (Interim) of Fiscal Year Ending March 2027 - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-11-11T09:43:52+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-8275\/ir\/8275-20261111-01_wp_financial_summary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Financial Summary for the Second Quarter (Interim) of Fiscal Year Ending March 2027"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"57189","title":"FORVAL CORP","ticker":"8275"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/149332","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=149332"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/149332\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=149332"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=149332"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=149332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}